You May Also Like

Myths and facts about COVID-19 vaccines
Cite
CITE Title : Myths and facts about COVID-19 vaccines Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : June 19, 2022 URL : https://stacks.cdc.gov/view/cdc/118619 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2022). Myths and facts about COVID-19 vaccines. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Myths and facts about COVID-19 vaccines" (2022) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Myths and facts about COVID-19 vaccines" , 2022 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 1.69 MB]
Corporate Authors:
National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
June 19, 2022
Description:
Updated June 19, 2022Accurate vaccine information is critical and can help stop common myths and rumors. It can be difficult to know which sources of ...
File Type:
[PDF - 1.69 MB]
File Type:
[PDF - 1.69 MB]

Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States
Cite
CITE Title : Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.) Published Date : August 23, 2021 URL : https://stacks.cdc.gov/view/cdc/109139 National Center for Immunization and Respiratory Diseases (U.S.) (2021). Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. National Center for Immunization and Respiratory Diseases (U.S.) "Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States" (2021) National Center for Immunization and Respiratory Diseases (U.S.) "Interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States" , 2021 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 3.79 MB]
Corporate Authors:
National Center for Immunization and Respiratory Diseases (U.S.)
August 23, 2021
Description:
Summary of recent changes (last updated August 13, 2021):New section on considerations for use of an additional dose of COVID-19 vaccine following a p...
File Type:
[PDF - 3.79 MB]
File Type:
[PDF - 3.79 MB]